BIOMAT Database Logo BIOMAT Database Logo

[Insulin and glucose metabolism in obesity (author's transl)]. 1979

K Ishikawa, and A Yamamoto

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

K Ishikawa, and A Yamamoto
[Carbohydrate metabolism and insulin --hyperinsulinism and insulin resistance in obesity-- (author's transl].
June 1979, Horumon to rinsho. Clinical endocrinology,
K Ishikawa, and A Yamamoto
[Immunoreactive insulin and obesity (author's transl)].
October 1975, Bratislavske lekarske listy,
K Ishikawa, and A Yamamoto
[Glucose and insulin metabolism in patients undergoing regular dialysis treatment (author's transl)].
October 1973, Klinische Wochenschrift,
K Ishikawa, and A Yamamoto
[A-V difference of blood glucose and insulin response in obesity (author's transl)].
June 1979, Horumon to rinsho. Clinical endocrinology,
K Ishikawa, and A Yamamoto
[Obesity and lipid metabolism (author's transl)].
January 1980, Horumon to rinsho. Clinical endocrinology,
K Ishikawa, and A Yamamoto
[Mechanism of insulin action on glucose and lipid metabolism in hepatocytes (author's transl)].
September 1981, Horumon to rinsho. Clinical endocrinology,
K Ishikawa, and A Yamamoto
[Abnormal glucose metabolism and insulin resistance in obesity].
June 1995, Nihon rinsho. Japanese journal of clinical medicine,
K Ishikawa, and A Yamamoto
[Impairment of glucose tolerance and involvement of insulin receptor in obesity of childhood (author's transl)].
September 1981, Horumon to rinsho. Clinical endocrinology,
K Ishikawa, and A Yamamoto
[GIK (glucose-insulin-potassium) therapy (author's transl)].
June 1977, Kokyu to junkan. Respiration & circulation,
K Ishikawa, and A Yamamoto
[Metabolism of adipose tissue and obesity (author's transl)].
October 1974, Casopis lekaru ceskych,
Copied contents to your clipboard!